Ali Faraz (CIK 1667937) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell TNYA (5,837 shares), Sell TNYA (3,969 shares), Sell TNYA (5,020 shares), Sell TNYA (7,406 shares), Sell TNYA (3,390 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,837 | $4,143 |
| 2026-08-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,969 | $2,817 |
| 2026-08-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,020 | $3,563 |
| 2026-08-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 7,406 | $5,256 |
| 2026-05-19 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,390 | $2,690 |
| 2026-02-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,851 | $3,745 |
| 2026-02-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,979 | $2,547 |
| 2026-02-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,032 | $3,220 |
| 2026-02-05 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Buy | 158,600 | $0 |
| 2025-11-17 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,126 | $4,158 |
| 2025-08-18 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,720 | $7,150 |
| 2025-08-18 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,893 | $4,866 |
| 2025-08-18 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 4,920 | $6,150 |
| 2025-05-16 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,189 | $1,403 |
| 2025-03-10 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 5,794 | $3,129 |
| 2025-03-10 | Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer | Sell | 3,947 | $2,131 |
Source: SEC Form 4 filings · as of 2026-08-17